Avance Clinical is the largest premium full-service Australian and North American CRO delivering quality clinical trials with globally accepted data, in Australia, New Zealand and the US. The company's clients are completing Phase I to Phase III of drug development programs which require fast, agile, and adaptive solution-oriented clinical research services. Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past four years, has been providing CRO services in the region for more than 26 years.
Avance Clinical offers pre-clinical services with their experienced ClinicReady team from pre-clinical through to Phase III clinical services, leveraging significant Australian Government incentive rebates of up to 43.5% and rapid start-up regulatory processes. With experience across more than 120 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review. Avance Clinical uses state-of-the-art technology and systems across all functional areas. Tech partners include Medidata, Oracle, TrialHub, Certinia, Salesforce, Zelta and Medrio. Learn more at www.avancecro.com.